Literature DB >> 35063118

Riluzole and spinocerebellar ataxia type 2: the ATRIL trial.

Luis Velázquez-Pérez1, Roberto Rodríguez-Labrada2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35063118     DOI： 10.1016/S1474-4422(22)00028-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

Review 1.  Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review.

Authors:  Iván Nicolas Ayala; Syed Aziz; Jennifer M Argudo; Mario Yepez; Mikaela Camacho; Diego Ojeda; Alex S Aguirre; Sebastian Oña; Andres F Andrade; Ananya Vasudhar; Juan A Moncayo; Gashaw Hassen; Juan Fernando Ortiz; Willian Tambo
Journal:  Brain Sci       Date:  2022-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.